{"id":5114,"date":"2018-12-21T14:37:34","date_gmt":"2018-12-21T14:37:34","guid":{"rendered":"http:\/\/www.library.sath.nhs.uk\/research\/?p=5114"},"modified":"2021-03-09T09:58:05","modified_gmt":"2021-03-09T09:58:05","slug":"steroid-induced-diabetes-and-hyperglycaemia-part-1-mechanisms-and-risks-2018","status":"publish","type":"post","link":"https:\/\/www.library.sath.nhs.uk\/research\/2018\/12\/21\/steroid-induced-diabetes-and-hyperglycaemia-part-1-mechanisms-and-risks-2018\/","title":{"rendered":"Steroid-induced diabetes and hyperglycaemia. Part 1: mechanisms and risks (2018)"},"content":{"rendered":"<p><strong>Type of publication:<\/strong><br \/>\nJournal article<\/p>\n<p><strong>Author(s):<\/strong><br \/>\n*Morris, David<\/p>\n<p><strong>Citation:<\/strong><br \/>\nDiabetes &amp; Primary Care; Aug 2018; vol. 20 (no. 4); p. 151-153<\/p>\n<p><strong>Abstract:<\/strong><br \/>\nGlucocorticoids are prescribed widely in primary care for the treatment of a range of conditions. Courses of treatment are usually short, but around 22% of use continues for over 6 months. As well as their therapeutic actions, glucocorticoids have a powerful impact on glucose metabolism, contributing to hyperglycaemia and a predisposition to diabetes. In the first of two articles on steroid-induced hyperglycaemia and diabetes, the author outlines the scale of the problem and explains the mechanisms by which glucocorticoids induce hyperglycaemia. High-risk situations are identified, and the short- and long-term dangers summarised. The second article will appear in the next issue of this journal.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Type of publication: Journal article Author(s): *Morris, David Citation: Diabetes &amp; Primary Care; Aug 2018; vol. 20 (no. 4); p. 151-153 Abstract: Glucocorticoids are prescribed widely in primary care for the treatment of a range of conditions. Courses of treatment<span class=\"ellipsis\">&hellip;<\/span><\/p>\n<div class=\"read-more\"><a href=\"https:\/\/www.library.sath.nhs.uk\/research\/2018\/12\/21\/steroid-induced-diabetes-and-hyperglycaemia-part-1-mechanisms-and-risks-2018\/\">Read more <span class=\"screen-reader-text\">Steroid-induced diabetes and hyperglycaemia. Part 1: mechanisms and risks (2018)<\/span><span class=\"meta-nav\"> &#8250;<\/span><\/a><\/div>\n<p><!-- end of .read-more --><\/p>\n","protected":false},"author":12,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"content-type":"","footnotes":""},"categories":[200],"tags":[768,64,989],"class_list":["post-5114","post","type-post","status-publish","format-standard","hentry","category-staff-publication","tag-768","tag-diabetes","tag-endocrinology-and-diabetes"],"_links":{"self":[{"href":"https:\/\/www.library.sath.nhs.uk\/research\/wp-json\/wp\/v2\/posts\/5114","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.library.sath.nhs.uk\/research\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.library.sath.nhs.uk\/research\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.library.sath.nhs.uk\/research\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.library.sath.nhs.uk\/research\/wp-json\/wp\/v2\/comments?post=5114"}],"version-history":[{"count":1,"href":"https:\/\/www.library.sath.nhs.uk\/research\/wp-json\/wp\/v2\/posts\/5114\/revisions"}],"predecessor-version":[{"id":5118,"href":"https:\/\/www.library.sath.nhs.uk\/research\/wp-json\/wp\/v2\/posts\/5114\/revisions\/5118"}],"wp:attachment":[{"href":"https:\/\/www.library.sath.nhs.uk\/research\/wp-json\/wp\/v2\/media?parent=5114"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.library.sath.nhs.uk\/research\/wp-json\/wp\/v2\/categories?post=5114"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.library.sath.nhs.uk\/research\/wp-json\/wp\/v2\/tags?post=5114"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}